Aptevo Therapeutics Chief Scientific Officer Jane Gross, To Present At Upcoming Cambridge Health Institute PEGS Virtual Conference Jul. 19-22
Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™
48 Biggest Movers From Yesterday
Gainers
Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.
Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Lydall Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 1.71% to 33,857.87 while the NASDAQ rose 0.63% to 14,119.16. The S&P also rose, gaining 1.28% to 4,219.92.
31 Stocks Moving In Monday’s Mid-Day Session
Gainers
Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.